Pfizer Inc.’s (PFE)’s Stock Price Update:
Pfizer Inc.’s (PFE) stock price ended its day with a gain of 1.20% and finalized at the price of $31.92. During its last trading session, Stock traded with the total exchanged volume of 21.63 million shares. The average volume stands around 23.81 million shares. The average numbers of shares are traded in a security per day, during the recent 3-month period. The stock has relative volume of 0.91. Relative volume is ratio between current volume and 3-month average value, intraday adjusted. Pfizer Inc.’s (PFE) is a part of Healthcare sector and belongs to Drug Manufacturers - Major industry.
USA based company, Pfizer Inc.’s (PFE)’s latest closing price distance was -2.40% from the average-price of 200 days while it maintained a distance from the 50 Day Moving Average at -1.10% and 1.75% compared with the 20 Day Moving Average.
Analysts’ mean recommendation for Pfizer Inc.’s (PFE) stands at 2.40. Rating Scale; where 1.0 rating means Strong Buy, 2.0 rating signify Buy, 3.0 recommendation reveals Hold, 4.0 rating score shows Sell and 5.0 displays Strong Sell signal.
To review the PFE previous performance, look at its past history, which highlighted below:
During last 5 trades the stock sticks almost 1.11%.
During last one month it showed the change of 0.97%.
During last 3 month it remained at -7.57%.
Along with these its year to date performance is standing at 2.62%.
ATR value of company was 0.66. Average True Range (ATR) is an indicator based on trading ranges smoothed by an N-period exponential moving average percentage of the true range values. ATR can display volatility of stocks, ETFs and indexes. The principal of ATR is very similar to other volatility indicators: A high ATR value signals a possible trend change. A low ATR value correlates with a weaker trend movement.
Relative Strength Index (RSI) was 50.96. The stock volatility for week was 1.70% while for month was 2.15%.The stock, as of last close, traded 16.10% to its 52 week low and was changed -13.06% from its 52 week high. Beta factor, which measures the riskiness of the security, was observed as 0.89. PFE’s value Change from Open was at 0.22% with a Gap of 0.98%.
EPS in next five year years is expected to touch 6.31% while EPS growth in past 5 year was 1.60% along with sales growth of -5.60% in the last five years.
EPS growth in next year is estimated to reach 8.70% while EPS growth estimate for this year is set at -21.50%.
The price/earnings ratio (P/E) is 31.86 and the forward P/E ratio stands at 12.17. The price to earnings growth is 5.05 and the price to sales ratio is 17. It has a dividend yield of 3.76%.
Analysts are expecting Pfizer, Inc. (PFE) to achieve $37.86 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $53.00 however minimum price target advised by analysts is $33.00. The Median price target for the stock is measured at $37.00. Three Months Ago, Analysts recommended an average brokerage rating of Overweight derived from brokerage firms, according to FactSet. 11 said a “Buy Rating” and 4 announced “Overweight Rating”. 7 advised “Hold Rating” regarding the stock. 0 announced “Sell Rating” and 0 disclosed “Underweight Rating”.
Currently Pfizer, Inc. (PFE) captured an average recommendation of “ Overweight ” from analysts. The stock has been suggested as “Buy” from “9″ Analysts”. “0” rated “Sell” for the company. “11” said the company as a “Hold”. Overweight rating was given by “3” and Underweight rating was given by “0”.